Kanagawa, Japan

Munehiro Oda


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 158(Granted Patents)


Location History:

  • Tokyo, JP (1983)
  • Kanagawa, JP (2000 - 2012)
  • Odawara, JP (1998 - 2014)

Company Filing History:


Years Active: 1983-2014

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceuticals: The Contributions of Munehiro Oda

Introduction: Munehiro Oda, an accomplished inventor based in Kanagawa, Japan, has made significant strides in the field of pharmaceuticals. With a notable portfolio of nine patents, Oda has dedicated his research to developing innovative solutions aimed at addressing critical health issues. His work focuses on peptides and pharmaceutical compositions that target ischemic diseases, demonstrating his commitment to advancing medical science.

Latest Patents: Among his recent inventions, Oda developed a peptide that inhibits angiotensin-converting enzyme (ACE), pivotal for regulating blood pressure. This groundbreaking peptide can be incorporated into food, beverages, and pharmaceutical formulations, highlighting its versatility and potential health benefits. Furthermore, Oda's pharmaceutical compositions target ischemic diseases and cytopathy resulting from ischemia. Utilizing midkine family proteins as active ingredients, these compositions show efficacy in preventing and treating a range of cerebrovascular disorders including cerebral infarction, Alzheimer's disease, and related conditions. This innovation not only aims to improve patient outcomes but also addresses a significant gap in available treatments for these debilitating ailments.

Career Highlights: Throughout his career, Oda has demonstrated an unwavering dedication to innovation. His tenure at respected organizations such as Meiji Milk Products Company Limited and Meiji Dairies Corporation underscores his role in the development of prominent pharmaceutical products. His contributions to these companies reflect his ability to apply scientific knowledge to practical applications, ultimately benefiting public health.

Collaborations: Oda has collaborated with esteemed colleagues in his field, including Sadatoshi Sakuma and Shinya Ikematsu. These partnerships have fostered a rich environment for research and innovation, enabling the sharing of ideas and expertise that drive forward-thinking solutions in pharmaceuticals.

Conclusion: Munehiro Oda's contributions to the field of pharmaceuticals reflect his innovative spirit and commitment to improving healthcare outcomes. With his ongoing research and development of effective pharmaceutical compositions, Oda continues to inspire advancements in medical treatments for ischemic diseases. His work not only showcases his expertise as an inventor but also marks a significant impact on the industry, highlighting the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…